High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.
The FDA was all in on AI. Will that change?
High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.